Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
8 Results for "
CDK17
" in MedChemExpress (MCE) Product Catalog:
Products (8)
8 Results for "CDK17" in MCE Product Catalog:
Synonyms: (S,R,S)-AHPC-Me-PEG2-dabrafenib
Target:
Research Areas:
DD-03-156 is a potent and selective degrader of CDK17 and LIMK2. DD-03-156 is exquisite and makes an advanced starting point for the development of a chemical probe for the degradation of CDK17 .
Cat. No.: HY-RS02369
Target:
Research Areas:
CDK17 Human Pre-designed siRNA Set A contains three designed siRNAs for CDK17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS25295
Target:
Research Areas:
Cdk17 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cdk17 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS18806
Target:
Research Areas:
Cdk17 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cdk17 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-E70665
Target:
Research Areas:
CDK17 is highly expressed in terminally differentiated neurons, particularly those found in hippocampal regions and olfactory bulbs. CDK17/CycY Recombinant Human Active Protein Kinase is an ortholog of CDK17 .
Cat. No.: HY-E70666
Target:
Research Areas:
CDK17 is highly expressed in terminally differentiated neurons, particularly those found in hippocampal regions and olfactory bulbs. CDK17/p35NCK Recombinant Human Active Protein Kinase is an ortholog of CDK17 .
Cat. No.: HY-153718
CAS No.: 2416873-72-6
Research Areas:
KI-ARv-03 is a potent and selective ATP-competitive CDK9 inhibitor with an IC₅₀ of 0.15 μM (at 45 μM ATP), exhibiting over 130-fold selectivity against other CDKs (including CDK1-7). KI-ARv-03 reduces androgen receptor (AR)-driven transcription and proliferation in prostate cancer cells. KI-ARv-03 can be used for leukemia, pancreatic cancer, alveolar rhabdomyosarcoma (ARMS) and castration-resistant prostate cancer (CRPC) research. KI-ARv-03 is a ligand for target protein for PROTAC. KI-ARv-03 can be used to synthesize PROTAC KI-CDK9d-32 (HY-173523) [1][2].
Cat. No.: HY-P702697
Purity: ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: CDK17; cyclin-dependent kinase 17; PCTAIRE protein kinase 2 , PCTK2; PCTAIRE2; PCTAIRE-motif protein kinase 2; cell division protein kinase 17; protein kinase cdc2-related PCTAIRE-2; serine/threonine-protein kinase PCTAIRE-2; PCTK2;
Species:
Source:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
